WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010029300) BIS AROMATIC COMPOUNDS FOR USE IN THE TREATMENT OF INFLAMMATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/029300    International Application No.:    PCT/GB2009/002170
Publication Date: 18.03.2010 International Filing Date: 10.09.2009
IPC:
C07D 401/12 (2006.01), A61P 11/06 (2006.01), A61K 31/44 (2006.01)
Applicants: BIOLIPOX AB [SE/SE]; PO Box 303 S-751 05 Uppsala (SE) (For All Designated States Except US).
PELCMAN, Benjamin [SE/SE]; (SE) (For US Only).
ALMEIDA, Maria [SE/SE]; (SE) (For US Only).
KATKEVICS, Martins [LV/LV]; (LV) (For US Only).
NILSSON, Peter [SE/SE]; (SE) (For US Only).
SCHAAL, Wesley [US/SE]; (SE) (For US Only).
OLOFSSON, Kristofer [SE/SE]; (SE) (For US Only)
Inventors: PELCMAN, Benjamin; (SE).
ALMEIDA, Maria; (SE).
KATKEVICS, Martins; (LV).
NILSSON, Peter; (SE).
SCHAAL, Wesley; (SE).
OLOFSSON, Kristofer; (SE)
Agent: MCNEENEY, Stephen; POTTER CLARKSON LLP Park View House 58 The Ropewalk Nottingham NG1 5DD (GB)
Priority Data:
61/136,539 12.09.2008 US
Title (EN) BIS AROMATIC COMPOUNDS FOR USE IN THE TREATMENT OF INFLAMMATION
(FR) COMPOSÉS BIS-AROMATIQUES POUR UTILISATION DANS LE TRAITEMENT DE L’INFLAMMATION
Abstract: front page image
(EN)There is provided compounds of formula (I), wherein ring A, D1, D2a, D2b, D3, Y, Y1, L3 and Y3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C4 synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.
(FR)La présente invention concerne des composés de formule (I), dans laquelle le cycle A, D1, D2a, D2b, D3, Y, Y1, L3 et Y3 ont les définitions données dans la description, et des sels pharmaceutiquement acceptables de ceux-ci, lesdits composés étant utiles dans le traitement de maladies dans lesquelles l’inhibition de la leucotriène C4 synthase est souhaitée et/ou requise, et particulièrement dans le traitement d’un trouble respiratoire et/ou de l’inflammation.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)